Fructose Sodium Diphosphate for Injection

Sodium Fructose-1,6-Diphosphate Injection is used in the management of acute myocardial infarction (heart attack) to support myocardial energy metabolism. It helps improve cardiac contractility, enhance energy production in heart cells, and reduce ischemic damage during and after a heart attack.

It is used in the treatment of acute heart failure, where it helps restore normal myocardial energy metabolism, improving heart function and aiding in better circulation and oxygen delivery to tissues.

Sodium Fructose-1,6-Diphosphate helps improve cerebral ischemia by enhancing energy production in brain cells, promoting recovery and reducing ischemic damage, especially after a stroke.

This injection can be used during the post-surgical phase, particularly after cardiac or major surgeries, to support cellular energy metabolism and improve recovery by maintaining ATP levels, preventing energy deficits in critical tissues.

In critically ill patients with sepsis or shock, this injection supports tissue energy metabolism, reduces cellular damage caused by oxygen deprivation, and improves organ function, particularly in the heart and brain.

Used in cases of acute liver failure or cirrhosis, Sodium Fructose-1,6-Diphosphate helps promote energy production in liver cells, supporting detoxification processes and maintaining liver function.

It is useful for patients with mitochondrial diseases, metabolic myopathies, or other conditions involving impaired cellular energy production, as it helps provide essential intermediates for ATP production in tissues.